JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+5.16%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$6.06B
AUM Growth
+$6.06B
(+4.5%)
Cap. Flow
-$60.7M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
1,599
New
209
Increased
277
Reduced
318
Closed
555
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$308M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$61.2M |
| 3 |
Intuit
INTU
|
$55.5M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$52.8M |
| 5 |
Capital One
COF
|
$52.6M |
Top Sells
| 1 |
Apple
AAPL
|
$109M |
| 2 |
Meta Platforms (Facebook)
META
|
$74.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$67.7M |
| 4 |
Nasdaq
NDAQ
|
$60.7M |
| 5 |
Goldman Sachs
GS
|
$60.1M |
Sector Composition
| 1 | Healthcare | 14.44% |
| 2 | Financials | 12.53% |
| 3 | Technology | 10.24% |
| 4 | Industrials | 7.66% |
| 5 | Energy | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
uniQure
QURE
$954M
| $29.2M | 0.25% |
+2,095,931
| New | +$29.2M |
|
52
AbbVie
ABBV
$374B
| $28.4M | 0.24% |
152,796
-26,832
| -15% | -$4.98M |
|
53
Apogee Therapeutics
APGE
$2.27B
| $27.9M | 0.23% |
642,357
+220,561
| +52% | +$9.58M |
|
54
Boston Scientific
BSX
$159B
| $27.7M | 0.23% |
257,639
+168,761
| +190% | +$18.1M |
|
|
55
Apple
AAPL
$3.54T
| $27.3M | 0.23% |
132,871
-532,930
| -80% | -$109M |
|
56
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| $24.6M | 0.21% |
267,668
+124,294
| +87% | +$11.4M |
|
57
NVIDIA
NVDA
$4.15T
| $23.9M | 0.2% |
151,165
+45,176
| +43% | +$7.14M |
|
58
Taysha Gene Therapies
TSHA
$791M
| $23.8M | 0.2% |
10,313,733
+10,068,479
| +4,105% | +$23.3M |
|
59
Walmart
WMT
$793B
| $23.4M | 0.2% |
238,825
+188,446
| +374% | +$18.4M |
|
60
Cidara Therapeutics
CDTX
$1.61B
| $21.9M | 0.18% |
+450,000
| New | +$21.9M |
|
61
Regency Centers
REG
$13.1B
| $21.6M | 0.18% |
303,845
-131,845
| -30% | -$9.39M |
|
62
Coterra Energy
CTRA
$18.4B
| $21.2M | 0.18% |
835,149
+157,620
| +23% | +$4M |
|
63
Spyre Therapeutics
SYRE
$1.02B
| $20.8M | 0.17% |
1,388,854
+140,000
| +11% | +$2.1M |
|
64
Invesco S&P 500 Quality ETF
SPHQ
$15.1B
| $20.2M | 0.17% |
282,958
+10,002
| +4% | +$713K |
|
65
Immunome
IMNM
$892M
| $19.4M | 0.16% |
2,085,660
-202,340
| -9% | -$1.88M |
|
66
SPDR S&P Retail ETF
XRT
$428M
| $19.3M | 0.16% |
250,000
+169,000
| +209% | +$13M |
|
67
Thomson Reuters
TRI
$80B
| $18.9M | 0.16% |
+94,106
| New | +$18.9M |
|
68
iShares MSCI USA Quality Factor ETF
QUAL
$54.1B
| $18.3M | 0.15% |
100,102
-401
| -0.4% | -$73.3K |
|
69
Gulfport Energy Corp
GPOR
$3.01B
| $17.3M | 0.15% |
86,079
+23,050
| +37% | +$4.64M |
|
70
Sempra
SRE
$53.7B
| $17.1M | 0.14% |
225,030
+125,380
| +126% | +$9.5M |
|
71
Charles Schwab
SCHW
$175B
| $15.8M | 0.13% |
172,962
+92,592
| +115% | +$8.45M |
|
72
Bank of America
BAC
$371B
| $15.7M | 0.13% |
331,699
+279,980
| +541% | +$13.2M |
|
73
NextEra Energy, Inc.
NEE
$148B
| $15.7M | 0.13% |
225,786
-481,044
| -68% | -$33.4M |
|
74
IBM
IBM
$227B
| $15.5M | 0.13% |
52,645
+17,428
| +49% | +$5.14M |
|
75
Vertex Pharmaceuticals
VRTX
$102B
| $15.4M | 0.13% |
34,615
+15,131
| +78% | +$6.74M |
|